Data on Atopic Dermatitis Detailed by Researchers at Oregon Medical Research Center (Long-term 2-year Safety and Efficacy of Tralokinumab In Adults With Moderate-to-severe Atopic Dermatitis: Interim Analysis of the Ecztend Open-label Extension ...)

Source :: Health & Medicine Week. December 9, 2022, 1584
Publication Year :: 2022
Abstract: 2022 DEC 9 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Fresh data on Skin Diseases and Conditions - Atopic Dermatitis are presented in [...]

Subjects :: Analysis
Atopic dermatitis -- Analysis
Medical research -- Analysis
Labels -- Analysis
Adults -- Analysis
Medicine, Experimental -- Analysis

Tools